|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0005558,
umls-concept:C0025266,
umls-concept:C0034656,
umls-concept:C0205341,
umls-concept:C0231220,
umls-concept:C0281186,
umls-concept:C0392360,
umls-concept:C0439234,
umls-concept:C0439275,
umls-concept:C0599755,
umls-concept:C1274040,
umls-concept:C1707455
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-3-20
|
|
pubmed:abstractText |
The identification of predictors for prostate biopsy outcome at two screening rounds using a PSA>or=3.0 ng/ml as biopsy indication.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0270-4137
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Prostate 66:604-612, 2006. (c) 2005 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
604-12
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16388508-Aged,
pubmed-meshheading:16388508-Algorithms,
pubmed-meshheading:16388508-Biopsy,
pubmed-meshheading:16388508-Cohort Studies,
pubmed-meshheading:16388508-Follow-Up Studies,
pubmed-meshheading:16388508-Humans,
pubmed-meshheading:16388508-Male,
pubmed-meshheading:16388508-Middle Aged,
pubmed-meshheading:16388508-Netherlands,
pubmed-meshheading:16388508-Prostate,
pubmed-meshheading:16388508-Prostate-Specific Antigen,
pubmed-meshheading:16388508-Prostatic Neoplasms,
pubmed-meshheading:16388508-Registries
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC, Rotterdam).
|
|
pubmed:affiliation |
Department of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. m.roobol@erasmusmc.nl
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
